175 related articles for article (PubMed ID: 15037655)
1. Mitotic aberration coupled with centrosome amplification is induced by hepatitis B virus X oncoprotein via the Ras-mitogen-activated protein/extracellular signal-regulated kinase-mitogen-activated protein pathway.
Yun C; Cho H; Kim SJ; Lee JH; Park SY; Chan GK; Cho H
Mol Cancer Res; 2004 Mar; 2(3):159-69. PubMed ID: 15037655
[TBL] [Abstract][Full Text] [Related]
2. Centrosome amplification and multinuclear phenotypes are Induced by hydrogen peroxide.
Chae S; Yun C; Um H; Lee JH; Cho H
Exp Mol Med; 2005 Oct; 37(5):482-7. PubMed ID: 16264273
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles.
Forgues M; Difilippantonio MJ; Linke SP; Ried T; Nagashima K; Feden J; Valerie K; Fukasawa K; Wang XW
Mol Cell Biol; 2003 Aug; 23(15):5282-92. PubMed ID: 12861014
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.
Chung TW; Lee YC; Kim CH
FASEB J; 2004 Jul; 18(10):1123-5. PubMed ID: 15132991
[TBL] [Abstract][Full Text] [Related]
5. HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis.
Fujii R; Zhu C; Wen Y; Marusawa H; Bailly-Maitre B; Matsuzawa S; Zhang H; Kim Y; Bennett CF; Jiang W; Reed JC
Cancer Res; 2006 Sep; 66(18):9099-107. PubMed ID: 16982752
[TBL] [Abstract][Full Text] [Related]
6. Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability.
Jorquera R; Tanguay RM
Hum Mol Genet; 2001 Aug; 10(17):1741-52. PubMed ID: 11532983
[TBL] [Abstract][Full Text] [Related]
7. Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation.
Wen Y; Golubkov VS; Strongin AY; Jiang W; Reed JC
J Biol Chem; 2008 Feb; 283(5):2793-803. PubMed ID: 18032378
[TBL] [Abstract][Full Text] [Related]
8. Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis.
Matsuda Y; Ichida T
Med Mol Morphol; 2009 Sep; 42(3):138-42. PubMed ID: 19784739
[TBL] [Abstract][Full Text] [Related]
9. MAPK mediates RAS-induced chromosome instability.
Saavedra HI; Fukasawa K; Conn CW; Stambrook PJ
J Biol Chem; 1999 Dec; 274(53):38083-90. PubMed ID: 10608877
[TBL] [Abstract][Full Text] [Related]
10. Regulation of hepatitis B virus replication by the ras-mitogen-activated protein kinase signaling pathway.
Zheng Y; Li J; Johnson DL; Ou JH
J Virol; 2003 Jul; 77(14):7707-12. PubMed ID: 12829809
[TBL] [Abstract][Full Text] [Related]
11. Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras.
Klein NP; Schneider RJ
Mol Cell Biol; 1997 Nov; 17(11):6427-36. PubMed ID: 9343405
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of the centrosome cycle and the origin of chromosomal instability in cancer.
Lingle WL; Lukasiewicz K; Salisbury JL
Adv Exp Med Biol; 2005; 570():393-421. PubMed ID: 18727509
[TBL] [Abstract][Full Text] [Related]
13. Centrosomal protein TAX1BP2 inhibits centrosome-microtubules aberrations induced by hepatitis B virus X oncoprotein.
Li SK; Tang HC; Man-Hon Leung M; Zou W; Chan WL; Zhou Y; Oi-Lin Ng I; Ching YP
Cancer Lett; 2020 Nov; 492():147-161. PubMed ID: 32827601
[TBL] [Abstract][Full Text] [Related]
14. Subcellular localization and transcriptional repressor activity of HBx on p21(WAF1/Cip1) promoter is regulated by ERK-mediated phosphorylation.
Noh EJ; Jung HJ; Jeong G; Choi KS; Park HJ; Lee CH; Lee JS
Biochem Biophys Res Commun; 2004 Jul; 319(3):738-45. PubMed ID: 15184045
[TBL] [Abstract][Full Text] [Related]
15. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells.
Park EH; Koh SS; Srisuttee R; Cho IR; Min HJ; Jhun BH; Lee YS; Jang KL; Kim CH; Johnston RN; Chung YH
Cancer Gene Ther; 2009 May; 16(5):453-61. PubMed ID: 19096445
[TBL] [Abstract][Full Text] [Related]
16. 1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes.
Johansen C; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
J Invest Dermatol; 2003 Apr; 120(4):561-70. PubMed ID: 12648218
[TBL] [Abstract][Full Text] [Related]
17. The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway.
Saavedra HI; Knauf JA; Shirokawa JM; Wang J; Ouyang B; Elisei R; Stambrook PJ; Fagin JA
Oncogene; 2000 Aug; 19(34):3948-54. PubMed ID: 10951588
[TBL] [Abstract][Full Text] [Related]
18. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
20. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells.
Kim MS; Lee EJ; Kim HR; Moon A
Cancer Res; 2003 Sep; 63(17):5454-61. PubMed ID: 14500381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
